← Back to Insights

Growth · August 23, 2026

The Handoff From Lab to Shelf Is Where Most IP Dies

By Axel D'Addario

I've sat in enough R&D reviews to know the failure point isn't usually the science. It's the gap between a working prototype and a manufacturable, sellable, supportable product. That handoff gets almost no formal process in most companies, and it's where good ideas quietly go to die.

Build the Bridge Team Before You Need It

The teams that move fast from lab to shelf have someone whose whole job is translation: taking what engineering built and specifying what operations, sales, and packaging need to make it real. Without that role, R&D hands off a spec sheet, operations interprets it their own way, and six months later the launched product bears little resemblance to what was tested and validated.

I build that bridge function before the R&D project is even finished, not after. It sits in on late-stage development, flags manufacturability issues while they're still cheap to fix, and owns the commercial launch plan in parallel with the final engineering sprint.

Timelines Kill More Launches Than Technology

The second failure point is timeline mismatch. R&D operates on discovery time; commercial teams operate on calendar time tied to trade shows, retail buying windows, and marketing campaigns already booked. When those two clocks aren't synchronized early, you either launch a rushed product or miss the retail window you built the whole plan around.

I now set the commercial launch date first, working backward to development milestones, rather than letting R&D set the pace and hoping commercial can react in time. That forces hard conversations early about what's realistic, which is far better than a hard conversation after the trade show slot is already booked and the product isn't ready.

R&D output only becomes an asset once it's shipped, sold, and repeatable.